Oct 2024 $4 M No. 7 $2 to $10 million 1
Bio-Path Holdings Inc.: Raise no. 7, Oct 2024 × Investors in this round 1 investor had bought by the notice of Oct 22, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $340,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Aline P, Sherwood · Director Douglas P, Morris · Director Heath W. Cleaver · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On fees: “H.C. Wainwright & Co., LLC received the above sales commission and warrants to purchase up to an aggregate of 344,828 shares of the Company's common stock, par value $0.001 per share at an exercise price equal to $1.0875 per share as compensation.”On the amounts: “Includes the gross proceeds received in the offering.”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 22, 2024. Read the notice at the SEC .
equity, options SEC Jun 2024 $4 M No. 6 $2 to $10 million 1
Bio-Path Holdings Inc.: Raise no. 6, Jun 2024 × Investors in this round 1 investor had bought by the notice of Jun 13, 2024: 1 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $340,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Aline P. Sherwood · Director Douglas P. Morris · Director Heath W. Cleaver · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants as consideration.”On the amounts: “Includes the gross proceeds received in the offering.”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 13, 2024. Read the notice at the SEC .
equity, options SEC Apr 2024 $1 M No. 5 Under $2 million 3
Bio-Path Holdings Inc.: Raise no. 5, Apr 2024 × Investors in this round 3 investors had bought by the notice of Apr 26, 2024: 3 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $102,796
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Aline P. Sherwood · Director Douglas P. Morris · Director Heath W. Cleaver · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants as consideration, in connection with a registered direct offering by the Issuer, which is not reported on this Form D.”On the amounts: “"Includes warrants to purchase up to 375,000 shares of common stock and warrants to purchase up to 28,125 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants""), with an exercise price of $3.10 and $4.0313, respectively."”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 26, 2024. Read the notice at the SEC .
options SEC Nov 2022 $2 M No. 4 $2 to $10 million 5
Bio-Path Holdings Inc.: Raise no. 4, Nov 2022 × Investors in this round 5 investors had bought by the notice of Nov 18, 2022: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $140,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Aline D. Sherwood · Director Douglas P. Morris · Director Heath W. Cleaver · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ROTH Capital Partners, LLC (CRD 15407) · Newport Beach, California Sold in all US states Remarks in the notice On fees: “ROTH Capital Partners, LLC received the above sales commission in connection with a concurrent registered direct offering by the Issuer, which is not reported on this Form D.”On the amounts: “Includes warrants to purchase up to 800,000 shares of common stock issued to investors at an exercise price equal to $2.85 per share. As of the date hereof, no such warrants have been exercised.”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Nov 18, 2022. Read the notice at the SEC .
options SEC Mar 2019 $1 M No. 3 Under $2 million 4
Bio-Path Holdings Inc.: Raise no. 3, Mar 2019 × Investors in this round 4 investors had bought by the notice of Mar 18, 2019: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $1 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $1,295,001
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Douglas P. Morris · Director Heath W. Cleaver · Director Mark P. Colonnese · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants in connection with a registered direct offering by the Issuer, which is not reported on this Form D.”On the amounts: “"Includes warrants to purchase up to 42,775 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants"") and all underlying shares thereof."”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Mar 18, 2019. Read the notice at the SEC .
options SEC Sep 2018 $2 M No. 2 $2 to $10 million 4
Bio-Path Holdings Inc.: Raise no. 2, Sep 2018 × Investors in this round 4 investors had bought by the notice of Oct 5, 2018: 4 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $2 M offered
Smallest investment taken no minimum stated
What was sold options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions $102,899
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Peter H. Nielsen · Executive Officer, Director Douglas P. Morris · Director Heath W. Cleaver · Director Mark P. Colonnese · Director Paul D. Aubert · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round H.C. Wainwright & Co., LLC (CRD 375) · New York, New York Sold in all US states Remarks in the notice On fees: “H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants in connection with the private placement and a concurrent registered direct offering by the Issuer, which is not reported on this Form D.”On the amounts: “"Includes warrants to purchase (i) up to 2,261,538 shares of common stock issued to certain institutional investors and (ii) up to 135,692 shares of common stock issued to H.C. Wainwright & Co., LLC (""HCW Warrants""), and all underlying shares thereof."”Signed by Peter H. Nielsen, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Oct 5, 2018. Read the notice at the SEC .
options SEC May 2012 $1 M No. 1 Under $2 million 62
Bio-Path Holdings Inc.: Raise no. 1, May 2012 × Investors in this round 62 investors had bought by the notice of Nov 1, 2012: 62 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $1 M of $4 M offered; $3 M still to sell
Smallest investment taken $10,000
What was sold equity
Meant to last a year or less
Issuer's revenue No revenue
Sales commissions $400,000
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Utah People named in the notice Douglas P. Morris · Executive Officer, Director, Promoter Peter H. Nielsen · Executive Officer, Director Gillian P. Ivers-Read · Director Michael J. Garrison · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round ACAP FINANCIAL (CRD 07731) · Salt Lake City, Utah Sold in AZ, CA, ID, UT Remarks in the notice On fees: “Plus one share for every ten shares sold.”Signed by Douglas P. Morris, Vice President. Source: SEC Form D, newest notice filed Nov 1, 2012. Read the notice at the SEC .
equity SEC